Farms.com Home   News

Analysts Waiting For China To Act On Phase One Trade Deal

Analysts in the U.S. are waiting on the Chinese to make their move.
 
Dan Basse is president of AgResource Company in Chicago.
 
"We have this phase one agreement, the agreement was signed on the 15th of January. There's a 30-day period to implement that agreement. That means February 15th, which is this weekend. So next week we'll really start to see if the Chinese have any intentions of buying U.S. grains or ag products. It will be very important to the markets. There may be a little bit of flexibility to coronavirus, but overall the traders here want to see, taste and feel the Chinese demand before they get too rambunctious on the long side of the market."
 
The USDA released its February WASDE report Tuesday morning, which Basse says was very conservative with estimates about the Chinese phase one agreement.
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.